Terms: = Gastric cancer AND MTOR, FRAP2, FRAP1, 2475, ENSG00000198793, P42345, RAPT1, RAFT1, FRAP, FLJ44809 AND Diagnosis
34 results:
1. Integrated multi-omics analysis and machine learning developed a prognostic model based on mitochondrial function in a large multicenter cohort for gastric cancer.
Ma Y; Jin J; Xue Z; Zhao J; Cai W; Zhang W
J Transl Med; 2024 Apr; 22(1):381. PubMed ID: 38654380
[TBL] [Abstract] [Full Text] [Related]
2. [Study on the Role and Mechanism of METTL3 Mediating the Up-regulation of
m6A Modified Long Non-coding RNA THAP7-AS1 in Promoting the Occurrence of
Lung cancer].
Zhang Y; Wang Y; Liu M
Zhongguo Fei Ai Za Zhi; 2024 Jan; 26(12):919-933. PubMed ID: 38163978
[TBL] [Abstract] [Full Text] [Related]
3. Exploring the molecular pathogenesis, diagnosis and treatment of fibrolamellar hepatocellular carcinoma: A state of art review of the current literature.
Alshareefy Y; Shen CY; Prekash RJ
Pathol Res Pract; 2023 Aug; 248():154655. PubMed ID: 37429175
[TBL] [Abstract] [Full Text] [Related]
4. YWHAH activates the HMGA1/PI3K/AKT/mtor signaling pathway by positively regulating Fra-1 to affect the proliferation of gastric cancer cells.
He J; Zeng F; Jin XI; Liang L; Gao M; Li W; Li G; Zhou Y
Oncol Res; 2023; 31(4):615-630. PubMed ID: 37415737
[TBL] [Abstract] [Full Text] [Related]
5. Precision medicine in gastroenteropancreatic neuroendocrine neoplasms: Where are we in 2023?
Fazio N; La Salvia A
Best Pract Res Clin Endocrinol Metab; 2023 Sep; 37(5):101794. PubMed ID: 37414651
[TBL] [Abstract] [Full Text] [Related]
6. UQCRFS1 serves as a prognostic biomarker and promotes the progression of ovarian cancer.
Sun Q; Li J; Dong H; Zhan J; Xiong X; Ding J; Li Y; He L; Wang J
Sci Rep; 2023 May; 13(1):8335. PubMed ID: 37221238
[TBL] [Abstract] [Full Text] [Related]
7. Changes in the salivary metabolome in patients with chronic erosive gastritis.
Liu S; Zhang S; Chen H; Zhou P; Yang T; Lv J; Li H; Wang Y
BMC Gastroenterol; 2023 May; 23(1):161. PubMed ID: 37208605
[TBL] [Abstract] [Full Text] [Related]
8. Long Non-Coding RNAs (lncRNAs) as Regulators of the PI3K/AKT/mtor Pathway in gastric Carcinoma.
Riquelme I; Pérez-Moreno P; Mora-Lagos B; Ili C; Brebi P; Roa JC
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047267
[TBL] [Abstract] [Full Text] [Related]
9. The roles and mechanisms of circular RNAs related to mtor in cancers.
Cao C; Wang Y; Wu X; Li Z; Guo J; Sun W
J Clin Lab Anal; 2022 Dec; 36(12):e24783. PubMed ID: 36426933
[TBL] [Abstract] [Full Text] [Related]
10. Identification of novel key regulatory lncRNAs in gastric adenocarcinoma.
Razavi H; Katanforosh A
BMC Genomics; 2022 May; 23(1):352. PubMed ID: 35525925
[TBL] [Abstract] [Full Text] [Related]
11. Pitfalls in the diagnosis of yolk sac tumor: Lessons from a clinical trial.
Yang A; Patterson A; Pavlock T; Chen KS; Gagan J; Hatley ME; Frazier AL; Amatruda JF; Laetsch TW; Rakheja D
Pediatr Blood Cancer; 2022 Feb; 69(2):e29451. PubMed ID: 34866303
[TBL] [Abstract] [Full Text] [Related]
12. Rag GTPases suppress PRL-3 degradation and predict poor clinical diagnosis of cancer patients with low PRL-3 mRNA expression.
Shi Y; Xu S; Ngoi NYL; Hui Y; Ye Z
Biochem Biophys Res Commun; 2021 Oct; 576():108-116. PubMed ID: 34482023
[TBL] [Abstract] [Full Text] [Related]
13. Phase I Study of Docetaxel and Temsirolimus in Refractory Solid Tumors.
Amin M; Gao F; Terrero G; Picus J; Wang-Gillam A; Suresh R; Ma C; Tan B; Baggstrom M; Naughton MJ; Trull L; Belanger S; Fracasso PM; Lockhart AC
Am J Clin Oncol; 2021 Sep; 44(9):443-448. PubMed ID: 34310349
[TBL] [Abstract] [Full Text] [Related]
14. CCL21 activation of the MALAT1/SRSF1/mtor axis underpins the development of gastric carcinoma.
Fu Q; Tan X; Tang H; Liu J
J Transl Med; 2021 May; 19(1):210. PubMed ID: 34001131
[TBL] [Abstract] [Full Text] [Related]
15. Tuberous sclerosis patient with neuroendocrine carcinoma of the esophagogastric junction: A case report.
Ishida N; Miyazu T; Tamura S; Suzuki S; Tani S; Yamade M; Iwaizumi M; Osawa S; Hamaya Y; Shinmura K; Sugimura H; Miura K; Furuta T; Sugimoto K
World J Gastroenterol; 2020 Dec; 26(45):7263-7271. PubMed ID: 33362382
[TBL] [Abstract] [Full Text] [Related]
16. Circulating Irisin Levels and Redox Status Markers in Patients with gastric cancer: A Case-Control Study.
Shahidi S; Hejazi J; Moghimi M; Borji S; Zabihian S; Fathi M
Asian Pac J Cancer Prev; 2020 Oct; 21(10):2847-2851. PubMed ID: 33112539
[TBL] [Abstract] [Full Text] [Related]
17. Crosstalk between long non-coding RNA DLX6-AS1, microRNAs and signaling pathways: A pivotal molecular mechanism in human cancers.
Alizadeh A; Jebelli A; Baradaran B; Amini M; Oroojalian F; Hashemzaei M; Mokhtarzadeh A; Hamblin MR
Gene; 2021 Feb; 769():145224. PubMed ID: 33059027
[TBL] [Abstract] [Full Text] [Related]
18. Proteomic and transcriptomic studies of BGC823 cells stimulated with Helicobacter pylori isolates from gastric MALT lymphoma.
Zou Q; Zhang H; Meng F; He L; Zhang J; Xiao D
PLoS One; 2020; 15(9):e0238379. PubMed ID: 32915799
[TBL] [Abstract] [Full Text] [Related]
19. A systematic review and meta-analysis protocol of clinical characteristics and prognostic significance of mammalian target of rapamycin for gastric cancer patients.
Wang H; Li J
Medicine (Baltimore); 2020 Aug; 99(32):e21138. PubMed ID: 32769866
[TBL] [Abstract] [Full Text] [Related]
20. The comprehensive upstream transcription and downstream targeting regulation network of miRNAs reveal potential diagnostic roles in gastric cancer.
Zhang C; Zhang CD; Liang Y; Wu KZ; Pei JP; Dai DQ
Life Sci; 2020 Jul; 253():117741. PubMed ID: 32360623
[TBL] [Abstract] [Full Text] [Related]
[Next]
